Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tejpar, Sabine, Bertagnolli, Monica, Bosman, Fred, Lenz, Heinz-Joseph, Garraway, Levi, Waldman, Frederic, Warren, Robert, Bild, Andrea, Collins-Brennan, Denise, Hahn, Hejin, Harkin, D. Paul, Kennedy, Richard, Ilyas, Mohammad, Morreau, Hans, Proutski, Vitali, Swanton, Charles, Tomlinson, Ian, Delorenzi, Mauro, Fiocca, Roberto, Van Cutsem, Eric, Roth, Arnaud
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2010
Assuntos:
Academia-Pharma Intersect
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227961/
https://ncbi.nlm.nih.gov/pubmed/20350999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0233
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares